A phase IV trial of Cesamet [nabilone] given with standard antiemetic therapy foe chemotherapy-induced nausea and vomiting.
Phase of Trial: Phase IV
Latest Information Update: 13 Jul 2018
At a glance
- Drugs Nabilone (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Therapeutic Use
- 24 Jan 2008 Status changed from recruiting to discontinued. This study was terminated because enrollment was too slow, accorind to ClinicalTrials.gov.
- 21 Aug 2006 New trial record.